Clinical tool

International Prognostic Score (IPS) for Advanced Hodgkin Lymphoma

The Hasenclever score with seven factors

Updated: 27 October 20261 min read1 reference

International Prognostic Score (IPS or Hasenclever score) for advanced Hodgkin lymphoma.

This calculator needs JavaScript; the formula and its interpretation are in the text of this page.

An aid for clinicians; it does not replace clinical judgement, local protocols or the drug label. Double-check every result before prescribing.

Use

The IPS was derived from 5,141 patients with advanced Hodgkin lymphoma; each factor reduced 5-year freedom from progression by about 7–8% [1]. Treatment is now mostly adapted by interim PET, but the IPS is still used when choosing between ABVD, BV-AVD and BEACOPP and for trial entry. Regimens: ABVD, BV-AVD.

Related cancer types

References

1 reference
Show all referencesClose the reference list

Numbers in the text, such as [1], refer to these sources. Sources with a “Study card” button are summarised in the site’s evidence library.

  1. 1
    A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's DiseaseHasenclever D, Diehl V · N Engl J Med · 1998;339:1506-14

This page is based on reputable scientific sources and was last updated on 27 October 2026. The content of this website is for educational and informational purposes only and does not replace consultation, diagnosis or treatment by a specialist physician. Consult your treating physician about any treatment decision.